Endoprostheses including nickel-titanium alloys

• US 20070073374A1
• Filed: 09/29/2005
• Published: 03/29/2007
• Est. Priority Date: 09/29/2005
• Status: Abandoned Application

• Current Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Original Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Inventors: Anderl, Steven, Vietmeier, Kristopher
• Application Number:
  US11/240,443
• Publication Number:
  US 20070073374A1
• Time in Patent Office: Days
• US Class Current: 623/1.200
• CPC Class Codes: A61F 2/91 made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
• CPC Class Codes: A61F 2/915 with bands having a meander structure, adjacent bands being connected to each other
• CPC Class Codes: A61F 2002/91525 within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
• CPC Class Codes: A61F 2002/91533 characterised by the phase between adjacent bands
• CPC Class Codes: A61F 2002/91575 connected peak to trough

Abstract

Self-expanding endoprostheses, such as stents, have good fatigue resistance are disclosed.

Claims

1. An endoprosthesis comprising a generally tubular body adapted to self-expand from a first dimension to a second dimension to support a bodily vessel, the tubular body comprising an alloy comprising nickel and titanium, the alloy further comprising inclusions, wherein the largest inclusion is less than or equal to approximately 7 microns in length.

2. The endoprosthesis of claim 1, wherein the percent area concentration of inclusions is less than or equal to approximately 1%.

3. The endoprosthesis of claim 1, wherein the size of the largest inclusions is less than or equal to approximately 4 microns in length.

4. The endoprosthesis of claim 1, wherein the inclusions are present in a percent area concentration of less than or equal to approximately 0.4%.

5. The endoprosthesis of claim 1, wherein the inclusions comprise an element selected from the group consisting of nitrogen, oxygen, and carbon.

6. The endoprosthesis of claim 1, wherein the tubular body comprises an oxidized layer less than or equal to approximately 100 angstroms.

7. The endoprosthesis of claim 1, wherein the tubular body comprises an oxidized layer less than or equal to approximately 30 angstroms.

8. The endoprosthesis of claim 1, wherein the alloy comprises from approximately 50.1 atomic percent to approximately 51.5 atomic percent of nickel.

9. The endoprosthesis of claim 1, further comprising a drug carried by the tubular body.

10. The endoprosthesis of claim 1, wherein the tubular body has an inner diameter of from approximately 5 mm to approximately 8 mm.

11. An endoprosthesis comprising a body adapted to self-expand from a first dimension to a second dimension and capable of maintaining the patency of a bodily vessel, the body comprising an alloy comprising from approximately 50.1 atomic percent to approximately 51.5 atomic percent of nickel, and titanium, the alloy further comprising inclusions present in a percent area concentration of less than or equal to approximately 1%, the size of the largest inclusions being less than or equal to approximately 7 microns in length, wherein the tubular body comprises an oxidized layer less than or equal to approximately 100 angstroms.

12. The endoprosthesis of claim 11, wherein the inclusions are present in an percent area concentration of less than or equal to approximately 0.4%.

13. A method, comprising:

delivering an endoprosthesis comprising a generally tubular body into a bodily vessel, the tubular body comprising an alloy comprising nickel and titanium, the alloy further comprising inclusions, wherein the size of the largest inclusions is less than or equal to approximately 7 microns in length; and

self-expanding the tubular body to support the bodily vessel.

14. The method of claim 13, wherein the bodily vessel is a superficial femoral artery.

15. The method of claim 13, wherein the bodily vessel is a carotid artery.

16. The method of claim 13, wherein the inclusions are present in an percent area concentration of less than or equal to approximately 1%;

17. The method of claim 13, wherein the size of the largest inclusions is less than or equal to approximately 4 microns in length.

18. The method of claim 13, wherein the inclusions are present in a percent area concentration of less than or equal to approximately 0.4%.

19. The method of claim 13, wherein the inclusions comprise an element selected from the group consisting of nitrogen, oxygen, and carbon.

20. The method of claim 13, wherein the tubular body comprises an oxidized layer less than or equal to approximately 100 angstroms.

21. The method of claim 13, wherein the tubular body comprises an oxidized layer less than or equal to approximately 30 angstroms.

22. The method of claim 13, wherein the alloy comprises from approximately 50.1 atomic percent to approximately 51.5 atomic percent of nickel.

23. The method of claim 13, wherein the tubular body carries a drug.

24. The method of claim 13, wherein the tubular body has an inner diameter of from approximately 5 mm to approximately 8 mm.